COPD: trials for referral
678 open trials in the registries we read. Each row links to its registry record.
Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.
Where the open trials are
Type a city to sort by distance. The distance is worked out in your browser; the city is not sent anywhere.
400 trials shown · Showing the 400 most recently updated of 678 open trials.
No phase1 site
RecruitingFrance
NCT06811402
Combinaison of Virtual Reality and Rehabilitation to Improve Muscle Function, Exercise Tolerance, Exertional Symptoms and Dyspnea in Patients With Chronic Respiratory Disease: a Randomized Cross-over Trial
Fondation Hôpital Saint-Joseph
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govNo phase0 sites
Not yet recruiting
NCT07913334
Impact of Nurse-Led Pulmonary Rehabilitation on Dyspnea, Fatigue and Self-Efficacy in COPD Patients
University of Health Sciences Lahore
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govNo phase1 site
Not yet recruitingTaiwan
NCT07867535
High-Intensity Interval Alternating Concentric-Eccentric Training in Chronic Respiratory Disease
Fu Jen Catholic University Hospital
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govPhase 11 site
Not yet recruitingUnited States
NCT07275359
Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations
Duke University
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govNo phase3 sites
Not yet recruitingUnited States
NCT07914010
Reducing Exposure With Air Cleaners and Technology
University of California, Berkeley
Registry updated 3 Nov 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingSwitzerland
NCT02065921
Swiss Chronic Obstructive Pulmonary Disease (COPD) Management Cohort
Prof. Dr. Jörg Leuppi
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingIndonesia
NCT07910006
Multimodal Assessment of NMES Effects on Respiratory and Peripheral Muscles in COPD
Universitas Padjadjaran
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.govPhase 1/21 site
Not yet recruitingChina
NCT07477600
cfMSC Stem Cell Therapy Targeting COPD
Shenzhen Geno-Immune Medical Institute
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingChina
NCT07910409
Construction and Validation of an Impulse Oscillometry (IOS)-Based Platform for Screening, Diagnosis, and Management of Chronic Airway Diseases
Beijing Chao Yang Hospital
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.govNo phase1 site
By invitation onlyUnited States
NCT07867184
Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)
National Institute of Allergy and Infectious Diseases (NIAID)
Registry updated 2 Nov 2026
Registry record: ClinicalTrials.govPhase 30 sites
Not yet recruiting
NCT07907991
The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary Disease
Boehringer Ingelheim
Registry updated 30 Oct 2026
Registry record: ClinicalTrials.govNo phase1 site
Not yet recruitingFrance
NCT07907601
Impact of Multidisciplinary Care, Structured and Targeted on the COPD Patient's Clinical Pathway.
Centre Hospitalier Universitaire de Nīmes
Registry updated 30 Oct 2026
Registry record: ClinicalTrials.govPhase 25 sites
RecruitingAustralia
NCT07730281
PRA-216 COPD Safety and Biomarker Study
Prana Therapies Inc
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.govPhase 235 sites
RecruitingCanada, Georgia, Moldova, United States
NCT07684820
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
Expedition Therapeutics, Inc
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.govPhase 22 sites
RecruitingUnited Kingdom
NCT07896252
Phase 2b Efficacy and Safety Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD Patients
AeroRx Therapeutics Inc.
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.govNo phase1 site
Not yet recruitingSpain
NCT07679646
Effectiveness and Efficiency of Home Telemonitoring and Non-invasive Ventilation in Patients With COPD and Hypercapnia (EVALECO)
Air Liquide Healthcare Spain
Registry updated 28 Oct 2026
Registry record: ClinicalTrials.govPhase 223 sites
RecruitingChina, United States
NCT07725939
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
UCB Biopharma SRL
Registry updated 27 Oct 2026
Registry record: ClinicalTrials.govNo phase4 sites
RecruitingFrance
NCT06257329
Characteristics and Outcomes of Patients Admitted to ICU for a Severe Acute Exacerbation of COPD.
Alexis FERRE
Registry updated 27 Oct 2026
Registry record: ClinicalTrials.govPhase 23 sites
RecruitingUnited States
NCT07705737
Rademikibart IV for Acute Asthma and COPD Exacerbation
Connect Biopharm LLC
Registry updated 27 Oct 2026
Registry record: ClinicalTrials.govNo phase3 sites
RecruitingUnited States
NCT05572632
Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
University of California, San Francisco
Registry updated 27 Oct 2026
Registry record: ClinicalTrials.govNo phase2 sites
RecruitingUnited Kingdom
NCT07798596
Comparing Advanced Technologies to Standard Testing for the Diagnosis of Airway Disease in Hospital and Community Settings
University Hospital Southampton NHS Foundation Trust
Registry updated 27 Oct 2026
Registry record: ClinicalTrials.govPhase 41 site
RecruitingUnited States
NCT07135427
Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
University of Alabama at Birmingham
Registry updated 27 Oct 2026
Registry record: ClinicalTrials.govPhase 31 site
Not yet recruitingBrazil
NCT06234345
Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)
Eurofarma Laboratorios S.A.
Registry updated 26 Oct 2026
Registry record: ClinicalTrials.govPhase 25 sites
Not yet recruitingDenmark, Spain, Italy, Netherlands
2025-522359-24-00
The MAB Trial: A Study of Tozorakimab to Reduce Lung Inflammation and Promote Lung Healing in People with COPD.
University Of Leicester
Registry updated 26 Oct 2026
Registry record: EU CTISPhase 322 sites
RecruitingGermany, Denmark, Spain, Ireland, Netherlands, Poland
NCT07555483
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Grifols Therapeutics LLC
Pre-treatment window Registry sentence: “If the total alpha1-PI serum (alpha-1 antitrypsin \[AAT\]) level has yet to be documented as in a treatment-naïve patient, a blood draw for total alpha1-PI serum level will be obtained at the Screening Visit.”
Registry updated 26 Oct 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingCanada
NCT07536178
Lungs on Fire: Wildfire Smoke, Incident Diseases, Susceptible Populations, and Community Values in Canada
University of British Columbia
Registry updated 26 Oct 2026
Registry record: ClinicalTrials.govPhase 3314 sites
RecruitingArgentina, Australia, Brazil, Canada, Chile, China
NCT07190222
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Sanofi
Registry updated 23 Oct 2026
Registry record: ClinicalTrials.govNo phase1 site
RecruitingUnited States
NCT01776398
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
Weill Medical College of Cornell University
Registry updated 23 Oct 2026
Registry record: ClinicalTrials.govPhase 217 sites
RecruitingArgentina, United States
NCT07646587
A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
Windward Bio
Registry updated 23 Oct 2026
Registry record: ClinicalTrials.govNo phase4 sites
RecruitingChina
NCT07656142
A Personalized Mobile Application Providing Temperature-Related Health Risk Warnings and Protective Recommendations for Patients With Chronic Obstructive Pulmonary Disease
Tiantian Li
Registry updated 23 Oct 2026
Registry record: ClinicalTrials.gov
The same sites as a list
- United States98 open trials
- China55 open trials
- France43 open trials
- United Kingdom36 open trials
- Denmark27 open trials
- Italy27 open trials
- Spain23 open trials
- Germany23 open trials
- Canada22 open trials
- Taiwan19 open trials
- Netherlands15 open trials
- Poland14 open trials
- Australia13 open trials
- Sweden13 open trials
- Hungary13 open trials
- Argentina12 open trials
- South Korea11 open trials
- Pakistan11 open trials
- Brazil10 open trials
- Greece10 open trials
- Japan9 open trials
- Belgium9 open trials
- Egypt9 open trials
- Switzerland8 open trials
- Israel8 open trials
- Romania8 open trials
- Bulgaria8 open trials
- Portugal7 open trials
- Austria7 open trials
- Czechia6 open trials
- Mexico6 open trials
- India6 open trials
- Hong Kong SAR China6 open trials
- New Zealand5 open trials
- Chile5 open trials
- Saudi Arabia5 open trials
- Indonesia4 open trials
- Malaysia4 open trials
- Vietnam4 open trials
- Thailand4 open trials
- Russia4 open trials
- Georgia3 open trials
- Slovakia3 open trials
- Norway3 open trials
- Colombia3 open trials
- Moldova2 open trials
- Ireland2 open trials
- South Africa2 open trials
- Lithuania2 open trials
- Ukraine2 open trials
- Singapore2 open trials
- Latvia2 open trials
- United Arab Emirates2 open trials
- Peru2 open trials
- Croatia2 open trials
- Philippines2 open trials
- Puerto Rico1 open trials
- Tunisia1 open trials
- Jordan1 open trials
- Estonia1 open trials
- Finland1 open trials
- Slovenia1 open trials
Who treats this
Institutions with trials or publications in this disease (OpenAlex, registries). Institutions only, no people.
Beijing Chao-Yang Hospital, Capital Medical University
Beijing, China
2 trials · 49 publications · ROR
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias
Madrid, Spain
0 trials · 172 publications · ROR
Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, China
0 trials · 193 publications · ROR
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
Barcelona, Spain
0 trials · 76 publications · ROR
First Affiliated Hospital of Guangzhou Medical University
Guangzhou, China
2 trials · 243 publications · ROR
First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Zhengzhou, China
0 trials · 60 publications · ROR
Manchester University NHS Foundation Trust
Manchester, United Kingdom
1 trials · 81 publications · ROR
National Institute for Health and Care Research
London, United Kingdom
0 trials · 46 publications · ROR
The University of Texas at San Antonio Health Science Center
San Antonio, United States
0 trials · 47 publications · ROR
University of California, San Francisco
San Francisco, United States
6 trials · 141 publications · ROR
University of Electronic Science and Technology of China
Chengdu, China
0 trials · 50 publications · ROR
University of Massachusetts Chan Medical School
Worcester, United States
2 trials · 77 publications · ROR
University of North Carolina at Chapel Hill
Chapel Hill, United States
1 trials · 128 publications · ROR
What changed in the last 7 days
Registry facts, one per line, newest first.
Phase changed: No phase → Phase 4
Immuno-inflammatory Response of Erdosteine in COPD
NCT07329946 · Phase 4 · Italy
Source: ClinicalTrials.gov
Results card
Trials that finished or stopped in the last 3 years, with the reason the registry gives and linked publications.
Phase 1Ended 9 Oct 2026
Completed24 participants
NCT07802730
Phase 1 PK Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD Patients
No phaseEnded 30 Sept 2026
Completed2000 participants
NCT01177618
Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
No phaseEnded 27 Sept 2026
Completed777 participants
NCT07886346
COPD Prevalence and Risk Factors Among Saudi Adults Over 18 in Taif
No phaseEnded 21 Sept 2026
Completed265 participants
NCT07181915
Changing Outcomes Through Achievement Emails in COPD Using Routine Healthcare Audits
Phase 3Ended 21 Sept 2026
No phaseEnded 21 Sept 2026
Completed1368 participants
NCT06646419
Boosting Regional Integration for COP D Care Through Guided Implementation and Audit of Post Exacerbation Transition Bundle
Phase 3Ended 10 Sept 2026
Completed669 participants
NCT06208306
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
No phaseEnded 27 Aug 2026
Phase 2Ended 26 Aug 2026
Completed159 participants
NCT06940154
Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)
No phaseEnded 20 Aug 2026
Phase 3Ended 19 Aug 2026
Completed1380 participants
NCT05595642
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Phase 2Ended 17 Aug 2026
Phase 1Ended 14 Aug 2026
Phase 1Ended 7 Aug 2026
Completed113 participants
NCT06748079
A Clinical Study of TQC3721 Inhalation Powder in Patients With Chronic Obstructive Pulmonary Disease
No phaseEnded 6 Aug 2026
Completed693 participants
NCT05854901
PCT-guided Treatment Regarding Antibiotic Use for Acute COPD Exacerbations
Phase 3Ended 5 Aug 2026
No phaseEnded 1 Aug 2026
No phaseEnded 1 Aug 2026
Completed128 participants
NCT07020299
Effect of Electrical Diaphragmatic Stimulation on Chronic Obstructive Pulmonary Disease
Phase 2Ended 31 Jul 2026
Completed25 participants
NCT05607719
Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPD
No phaseEnded 30 Jul 2026
Phase 2Ended 29 Jul 2026
No phaseEnded 20 Jul 2026
No phaseEnded 1 Jul 2026
No phaseEnded 30 Jun 2026
Completed40 participants
NCT07742033
Active Cycle Of Breathing Technique And Pursed Lip Breathing in Moderate to Severe COPD Patients
No phaseEnded 30 Jun 2026
No phaseEnded 30 Jun 2026
No phaseEnded 30 Jun 2026
No phaseEnded 30 Jun 2026
No phaseEnded 30 Jun 2026
Completed32 participants
NCT06614959
The Effects of Oscillatory Positive Expiratory Pressure (OPEP) Therapy in Patients With COPD
No phaseEnded 25 Jun 2026
Completed30 participants
NCT07348003
Examining the Effectiveness of Single-Limb Exercise Training for COPD Patients During Exacerbation Periods
No phaseEnded 22 Jun 2026
No phaseEnded 15 Jun 2026
No phaseEnded 12 Jun 2026
Completed270 participants
NCT07031401
Investigation of the Attitudes of Patients With Chronic Obstructive Pulmonary Disease Towards Traditional Complementary Medicine Practices
No phaseEnded 1 Jun 2026
Completed914 participants
NCT03927820
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
No phaseEnded 1 Jun 2026
Completed28 participants
NCT06891677
Internet-Based Cognitive Behavioral Therapy and Educational Program for People Living With Chronic Obstructive Pulmonary Disease (COPD)
No phaseEnded 1 Jun 2026
Phase 4Ended 29 May 2026
Completed60 participants
NCT04522596
Effect of Dual Bronchodilation With Umeclidinium/Vilanterol on Patients With COPD, Hyperinflation and Heart Failure
Phase 3Ended 27 May 2026
Completed1713 participants
NCT05742802
Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).
Phase 3Ended 22 May 2026
Completed1454 participants
NCT06040086
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
No phaseEnded 21 May 2026
Completed40 participants
NCT07790627
Effect of Utilizing Virtual Reality With Pulmonary Rehabilitation on Depression in COPD Patients
No phaseEnded 15 May 2026
Completed425 participants
NCT07223749
Validation of Chronic Obstructive Pulmonary Disease (COPD) Algorithm
No phaseEnded 15 May 2026
Completed68 participants
NCT07604961
Short-Term Inspiratory Muscle Training and Aerobic Exercise in Women With COPD
Phase 2Ended 7 May 2026
Completed195 participants
NCT07252908
A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder
No phaseEnded 5 May 2026
No phaseEnded 30 Apr 2026
No phaseEnded 30 Apr 2026
Completed40 participants
NCT07788092
Dupilumab in Type 2-Inflamed COPD Across the Full Spectrum of Airflow Limitation: An Italian Multicentre Retrospective Cohort Study
Phase 4Ended 30 Apr 2026
Completed1713 participants
NCT03566667
Beta-blockers to Patients With Chronic Obstructive Pulmonary Disease
No phaseEnded 28 Apr 2026
Phase 1Ended 22 Apr 2026
Phase 2Ended 21 Apr 2026
No phaseEnded 15 Apr 2026
Completed45 participants
NCT07288619
Therapeutic Efficacy of Nutritional Supplementation in Cachexia Associated With Chronic Pulmonary Disease
No phaseEnded 15 Apr 2026
No phaseEnded 10 Apr 2026
Completed439 participants
NCT04217330
An Implementation Trial to Improve Access to Pulmonary Rehabilitation in People With COPD
Phase 2Ended 10 Apr 2026
Completed100 participants
NCT07620912
Sedation vs No Sedation in Mechanically Ventilated COPD Patients
Phase 2Ended 2 Apr 2026
No phaseEnded 31 Mar 2026
No phaseEnded 31 Mar 2026
Completed9319 participants
NCT06456996
Impact of Multi-Component Interventions on High Risk COPD Population
No phaseEnded 31 Mar 2026
Completed54 participants
NCT06330623
Developing Personalised Relative Physical Activity Thresholds in COPD.
No phaseEnded 31 Mar 2026
No phaseEnded 30 Mar 2026
Not medical advice. fetched 4 Nov 2026